Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis
AimWe aimed to develop and validate a comprehensive nomogram containing pre-treatment plasma HSP90AA1 to predict the risk of breast cancer onset and metastasis.MethodsWe assessed the expression of HSP90s in breast cancer patients using an online database. To verify the results, 677 patients diagnose...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-05-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.639596/full |
| _version_ | 1819137315494166528 |
|---|---|
| author | Haizhou Liu Zihan Zhang Yi Huang Wene Wei Shufang Ning Jilin Li Xinqiang Liang Kaisheng Liu Litu Zhang |
| author_facet | Haizhou Liu Zihan Zhang Yi Huang Wene Wei Shufang Ning Jilin Li Xinqiang Liang Kaisheng Liu Litu Zhang |
| author_sort | Haizhou Liu |
| collection | DOAJ |
| description | AimWe aimed to develop and validate a comprehensive nomogram containing pre-treatment plasma HSP90AA1 to predict the risk of breast cancer onset and metastasis.MethodsWe assessed the expression of HSP90s in breast cancer patients using an online database. To verify the results, 677 patients diagnosed with breast cancer and 146 patients with benign breast disease between 2014 and 2019 were selected from our hospital and were divided into cancer risk and metastasis risk cohorts. We focused on HSP90AA1 to elucidate the risks of onset and metastasis in the cohorts.ResultsExpression levels of HSP90AA1, HSP90AA2, HSP90AB1, HSP90B1, and TRAP1 were linked to disease progression. Survival analysis using the GEPIA and OncoLnc databases indicated that the upregulation of HSP90AA1 and HSP90AB1 was related to poor overall survival. In the cancer risk cohort, carcinoembryonic antigen (CEA), carbohydrate antigen 153 (CA153), HSP90AA1, T cells%, natural killer cells%, B cells%, neutrophil count, monocyte count, and d-dimer were incorporated into the nomogram. A high Harrell’s concordance index (C-index) value of 0.771 [95% confidence interval (CI), 0.725–0.817] could still be reached in the interval validation. In the metastasis risk cohort, predictors contained in the prediction nomogram included the use of CEA, CA153, HSP90AA1, carbohydrate antigen 125 (CA125), natural killer cells%, B cells%, platelet count, monocyte count, and d-dimer. The C-index was 0.844 (95% CI, 0.801–0.887) and it was well-calibrated. HSP90AA1 raised net clinical benefit of breast cancer onset and metastasis risk prediction nomogram in a range of risk thresholds (5–92%) and (1–90%).ConclusionOur study revealed that pretreatment plasma HSP90AA1 combined with other markers could conveniently predict the risk of breast cancer onset and metastasis. |
| first_indexed | 2024-12-22T10:48:55Z |
| format | Article |
| id | doaj.art-3411009ba14f4feca9aab68fdfe4dd1e |
| institution | Directory Open Access Journal |
| issn | 2296-634X |
| language | English |
| last_indexed | 2024-12-22T10:48:55Z |
| publishDate | 2021-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cell and Developmental Biology |
| spelling | doaj.art-3411009ba14f4feca9aab68fdfe4dd1e2022-12-21T18:28:49ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-05-01910.3389/fcell.2021.639596639596Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant MetastasisHaizhou Liu0Zihan Zhang1Yi Huang2Wene Wei3Shufang Ning4Jilin Li5Xinqiang Liang6Kaisheng Liu7Litu Zhang8Department of Research, Affiliated Tumor Hospital, Guangxi Medical University, Nanning, ChinaDepartment of Research, Affiliated Tumor Hospital, Guangxi Medical University, Nanning, ChinaDepartment of Research, Affiliated Tumor Hospital, Guangxi Medical University, Nanning, ChinaDepartment of Research, Affiliated Tumor Hospital, Guangxi Medical University, Nanning, ChinaDepartment of Research, Affiliated Tumor Hospital, Guangxi Medical University, Nanning, ChinaDepartment of Research, Affiliated Tumor Hospital, Guangxi Medical University, Nanning, ChinaDepartment of Research, Affiliated Tumor Hospital, Guangxi Medical University, Nanning, ChinaShenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, ChinaDepartment of Research, Affiliated Tumor Hospital, Guangxi Medical University, Nanning, ChinaAimWe aimed to develop and validate a comprehensive nomogram containing pre-treatment plasma HSP90AA1 to predict the risk of breast cancer onset and metastasis.MethodsWe assessed the expression of HSP90s in breast cancer patients using an online database. To verify the results, 677 patients diagnosed with breast cancer and 146 patients with benign breast disease between 2014 and 2019 were selected from our hospital and were divided into cancer risk and metastasis risk cohorts. We focused on HSP90AA1 to elucidate the risks of onset and metastasis in the cohorts.ResultsExpression levels of HSP90AA1, HSP90AA2, HSP90AB1, HSP90B1, and TRAP1 were linked to disease progression. Survival analysis using the GEPIA and OncoLnc databases indicated that the upregulation of HSP90AA1 and HSP90AB1 was related to poor overall survival. In the cancer risk cohort, carcinoembryonic antigen (CEA), carbohydrate antigen 153 (CA153), HSP90AA1, T cells%, natural killer cells%, B cells%, neutrophil count, monocyte count, and d-dimer were incorporated into the nomogram. A high Harrell’s concordance index (C-index) value of 0.771 [95% confidence interval (CI), 0.725–0.817] could still be reached in the interval validation. In the metastasis risk cohort, predictors contained in the prediction nomogram included the use of CEA, CA153, HSP90AA1, carbohydrate antigen 125 (CA125), natural killer cells%, B cells%, platelet count, monocyte count, and d-dimer. The C-index was 0.844 (95% CI, 0.801–0.887) and it was well-calibrated. HSP90AA1 raised net clinical benefit of breast cancer onset and metastasis risk prediction nomogram in a range of risk thresholds (5–92%) and (1–90%).ConclusionOur study revealed that pretreatment plasma HSP90AA1 combined with other markers could conveniently predict the risk of breast cancer onset and metastasis.https://www.frontiersin.org/articles/10.3389/fcell.2021.639596/fullbreast cancermetastasisheat shock protein-90prognosisnomogram |
| spellingShingle | Haizhou Liu Zihan Zhang Yi Huang Wene Wei Shufang Ning Jilin Li Xinqiang Liang Kaisheng Liu Litu Zhang Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis Frontiers in Cell and Developmental Biology breast cancer metastasis heat shock protein-90 prognosis nomogram |
| title | Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis |
| title_full | Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis |
| title_fullStr | Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis |
| title_full_unstemmed | Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis |
| title_short | Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis |
| title_sort | plasma hsp90aa1 predicts the risk of breast cancer onset and distant metastasis |
| topic | breast cancer metastasis heat shock protein-90 prognosis nomogram |
| url | https://www.frontiersin.org/articles/10.3389/fcell.2021.639596/full |
| work_keys_str_mv | AT haizhouliu plasmahsp90aa1predictstheriskofbreastcanceronsetanddistantmetastasis AT zihanzhang plasmahsp90aa1predictstheriskofbreastcanceronsetanddistantmetastasis AT yihuang plasmahsp90aa1predictstheriskofbreastcanceronsetanddistantmetastasis AT wenewei plasmahsp90aa1predictstheriskofbreastcanceronsetanddistantmetastasis AT shufangning plasmahsp90aa1predictstheriskofbreastcanceronsetanddistantmetastasis AT jilinli plasmahsp90aa1predictstheriskofbreastcanceronsetanddistantmetastasis AT xinqiangliang plasmahsp90aa1predictstheriskofbreastcanceronsetanddistantmetastasis AT kaishengliu plasmahsp90aa1predictstheriskofbreastcanceronsetanddistantmetastasis AT lituzhang plasmahsp90aa1predictstheriskofbreastcanceronsetanddistantmetastasis |